246 related articles for article (PubMed ID: 9870078)
1. Transport of proteins across the human placenta.
Malek A; Sager R; Schneider H
Am J Reprod Immunol; 1998 Nov; 40(5):347-51. PubMed ID: 9870078
[TBL] [Abstract][Full Text] [Related]
2. Protein transport across the in vitro perfused human placenta.
Malek A; Sager R; Lang AB; Schneider H
Am J Reprod Immunol; 1997 Oct; 38(4):263-71. PubMed ID: 9352013
[TBL] [Abstract][Full Text] [Related]
3. Maternal serum testing for alpha-fetoprotein and human chorionic gonadotropin in high-risk pregnancies.
Jauniaux E; Gulbis B; Tunkel S; Ramsay B; Campbell S; Meuris S
Prenat Diagn; 1996 Dec; 16(12):1129-35. PubMed ID: 8994249
[TBL] [Abstract][Full Text] [Related]
4. Obstetrical complications associated with abnormal maternal serum markers analytes.
Gagnon A; Wilson RD;
J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
[TBL] [Abstract][Full Text] [Related]
5. Human cytotrophoblast cells cultured in maternal serum progress to a differentiated syncytial phenotype expressing both human chorionic gonadotropin and human placental lactogen.
Richards RG; Hartman SM; Handwerger S
Endocrinology; 1994 Jul; 135(1):321-9. PubMed ID: 8013368
[TBL] [Abstract][Full Text] [Related]
6. Antibodies against beta 2-glycoprotein I (beta 2-GP I) and their relationship to fetoplacental antigens.
Fialová L; Malhoban I; Mikulíková L; Benesová O; Zwinger A
Physiol Res; 2002; 51(5):449-55. PubMed ID: 12470197
[TBL] [Abstract][Full Text] [Related]
7. Predictors of poor perinatal outcome following maternal perception of reduced fetal movements--a prospective cohort study.
Dutton PJ; Warrander LK; Roberts SA; Bernatavicius G; Byrd LM; Gaze D; Kroll J; Jones RL; Sibley CP; Frøen JF; Heazell AE
PLoS One; 2012; 7(7):e39784. PubMed ID: 22808059
[TBL] [Abstract][Full Text] [Related]
8. The relationship of uterine and umbilical Doppler resistance to fetal and placental protein synthesis in the second trimester.
Bewley S; Chard T; Grudzinskas G; Campbell S
Placenta; 1993; 14(6):663-70. PubMed ID: 7512267
[TBL] [Abstract][Full Text] [Related]
9. Evolution of maternofetal transport of immunoglobulins during human pregnancy.
Malek A; Sager R; Kuhn P; Nicolaides KH; Schneider H
Am J Reprod Immunol; 1996 Nov; 36(5):248-55. PubMed ID: 8955500
[TBL] [Abstract][Full Text] [Related]
10. Leptin production and release in the dually in vitro perfused human placenta.
Linnemann K; Malek A; Sager R; Blum WF; Schneider H; Fusch C
J Clin Endocrinol Metab; 2000 Nov; 85(11):4298-301. PubMed ID: 11095471
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of alphafetoprotein transfer in the perfused human placental cotyledon from uncomplicated pregnancy.
Brownbill P; Edwards D; Jones C; Mahendran D; Owen D; Sibley C; Johnson R; Swanson P; Nelson DM
J Clin Invest; 1995 Nov; 96(5):2220-6. PubMed ID: 7593608
[TBL] [Abstract][Full Text] [Related]
12. Update on Transplacental Transfer of IgG Subclasses: Impact of Maternal and Fetal Factors.
Clements T; Rice TF; Vamvakas G; Barnett S; Barnes M; Donaldson B; Jones CE; Kampmann B; Holder B
Front Immunol; 2020; 11():1920. PubMed ID: 33013843
[TBL] [Abstract][Full Text] [Related]
13. M281, an anti-FcRn antibody, inhibits IgG transfer in a human ex vivo placental perfusion model.
Roy S; Nanovskaya T; Patrikeeva S; Cochran E; Parge V; Guess J; Schaeck J; Choudhury A; Ahmed M; Ling LE
Am J Obstet Gynecol; 2019 May; 220(5):498.e1-498.e9. PubMed ID: 30849355
[TBL] [Abstract][Full Text] [Related]
14. Placental transport of maternal immunoglobulin G in pregnancies at risk of Rh (D) hemolytic disease of the newborn.
Palfi M; Hildén JO; Gottvall T; Selbing A
Am J Reprod Immunol; 1998 May; 39(5):323-8. PubMed ID: 9602250
[TBL] [Abstract][Full Text] [Related]
15. Amniotic fluid hormone profiles during normal and abnormal pregnancy.
Sarandakou A; Kassanos D; Phocas I; Kontoravdis A; Chryssicopoulos A; Zourlas PA
Clin Exp Obstet Gynecol; 1992; 19(3):180-8. PubMed ID: 1280539
[TBL] [Abstract][Full Text] [Related]
16. C-reactive protein production in term human placental tissue.
Malek A; Bersinger NA; Di Santo S; Mueller MD; Sager R; Schneider H; Ghezzi F; Karousou E; Passi A; De Luca G; Raio L
Placenta; 2006; 27(6-7):619-25. PubMed ID: 16026834
[TBL] [Abstract][Full Text] [Related]
17. Purified first and third trimester placental trophoblasts differ in in vitro hormone secretion.
Kato Y; Braunstein GD
J Clin Endocrinol Metab; 1990 Apr; 70(4):1187-92. PubMed ID: 2318939
[TBL] [Abstract][Full Text] [Related]
18. Ex vivo human placenta models: transport of immunoglobulin G and its subclasses.
Malek A
Vaccine; 2003 Jul; 21(24):3362-4. PubMed ID: 12850340
[TBL] [Abstract][Full Text] [Related]
19. Capacity for hormone production of cultured trophoblast cells obtained from placentae at term and in early pregnancy.
Malek A; Willi A; Müller J; Sager R; Hänggi W; Bersinger N
J Assist Reprod Genet; 2001 May; 18(5):299-304. PubMed ID: 11464582
[TBL] [Abstract][Full Text] [Related]
20. Human chorionic gonadotrophin and alpha-fetoprotein levels in matched samples of amniotic fluid, extraembryonic coelomic fluid, and maternal serum in the first trimester of pregnancy.
Wathen NC; Cass PL; Kitau MJ; Chard T
Prenat Diagn; 1991 Mar; 11(3):145-51. PubMed ID: 1710066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
